Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Operating Expenses: 2023-2024

Historic Operating Expenses for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to $18.3 million.

  • Artiva Biotherapeutics' Operating Expenses rose 27.56% to $18.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $67.5 million, marking a year-over-year change of. This contributed to the annual value of $67.5 million for FY2024, which is 5.25% up from last year.
  • As of Q4 2024, Artiva Biotherapeutics' Operating Expenses stood at $18.3 million, which was down 0.37% from $18.3 million recorded in Q3 2024.
  • In the past 5 years, Artiva Biotherapeutics' Operating Expenses ranged from a high of $18.7 million in Q2 2023 and a low of $14.3 million during Q4 2023.
  • In the last 2 years, Artiva Biotherapeutics' Operating Expenses had a median value of $16.2 million in 2024 and averaged $16.6 million.
  • Data for Artiva Biotherapeutics' Operating Expenses shows a peak YoY increase of 27.56% (in 2024) and a maximum YoY decrease of 13.32% (in 2024) over the last 5 years.
  • Over the past 2 years, Artiva Biotherapeutics' Operating Expenses (Quarterly) stood at $14.3 million in 2023, then climbed by 27.56% to $18.3 million in 2024.
  • Its Operating Expenses was $18.3 million in Q4 2024, compared to $18.3 million in Q3 2024 and $16.2 million in Q2 2024.